RCKT financials
Rocket Pharmaceuticals (RCKT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- RCKT revenue was $0.00 in fiscal 2025, net income -$223.12M.
RCKT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | – | -$231.75M | -$223.12M | -2.01 |
| 2024 | $0.00 | – | -$273.20M | -$258.75M | -2.73 |
| 2023 | $0.00 | – | -$259.66M | -$245.59M | -2.92 |
| 2022 | $0.00 | – | -$224.34M | -$221.86M | -3.26 |
| 2021 | $0.00 | – | -$167.25M | -$169.07M | -2.67 |
| 2020 | $0.00 | – | -$134.30M | -$139.70M | -2.52 |